perylene has been researched along with Glioma in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (18.52) | 18.2507 |
2000's | 5 (18.52) | 29.6817 |
2010's | 15 (55.56) | 24.3611 |
2020's | 2 (7.41) | 2.80 |
Authors | Studies |
---|---|
Bassler, MC; Brecht, M; Meixner, AJ; Rammler, T; Ritz, R; Secic, I; Wackenhut, F; Zur Oven-Krockhaus, S | 1 |
Lin, G; Lin, H; Lin, R; Shen, Z; Wang, W; Zheng, S | 1 |
Huntosova, V; Kozar, T; Stroffekova, K; Tomkova, S | 1 |
Horvath, D; Huntosova, V; Miskovsky, P; Misuth, M | 1 |
Balogová, L; Dzurová, L; Maslaňáková, M; Miškovský, P; Stroffeková, K | 1 |
Ehrhardt, A; Feigl, GC; Göbel, W; Mayer, D; Naumann, U; Noell, S; Ritz, R; Serifi, D | 1 |
Dzurová, L; Huntosova, V; Miskovsky, P; Nadova, Z; Petrovajova, D; Stroffekova, K | 1 |
Agostinis, P; Boon, L; Garg, AD; Koks, C; Van Gool, SW; Vandenberk, L; Verschuere, T | 1 |
Belej, D; Horvath, D; Huntosova, V; Joniova, J; Jurasekova, Z; Kozar, T; Miskovsky, P; Stanicova, J; Verebova, V | 1 |
Belej, D; Horvath, D; Hrivnak, S; Huntosova, V; Joniova, J; Misuth, M | 1 |
Balogova, L; Huntosova, V; Maslanakova, M; Nichtova, Z; Novotova, M; Petrovajova, D; Stroffekova, K | 1 |
Dzurova, L; Horvath, D; Huntosova, V; Joniova, J; Miskovsky, P; Misuth, M; Nichtova, Z; Novotova, M; Stroffekova, K | 1 |
Shibata, Y | 1 |
Alvarez, L; Bonneau, S; Brault, D; Bryndzova, L; Buriankova, L; Huntosova, V; Jancura, D; Miskovsky, P; Nadova, Z; Sureau, F | 1 |
Mayer, D; Noell, S; Ritz, R; Strauss, WS; Tatagiba, MS | 1 |
Appley, AJ; Cabana, BE; Chen, TC; Couldwell, WT; Forsyth, PA; Hinton, DR; Spence, AM; Stillerman, CB; Surnock, AA; Tobia, AJ | 1 |
Bornemann, A; Daniels, R; Dietz, K; Feigl, GC; Mayer, D; Noell, S; Ramina, K; Ritz, R; Schmidt, V; Strauss, WS; Tatagiba, M | 1 |
Dzurova, L; Huntosova, V; Jakusova, V; Miskovsky, P; Nadova, Z; Sureau, F | 1 |
Fiebich, B; Pajonk, F; Scholber, J | 1 |
Dietz, K; Ritz, R; Roser, F; Schenk, M; Strauss, WS; Tatagiba, M; Wein, HT | 1 |
Bornemann, A; Dietz, K; Duffner, F; Müller, M; Ritz, R; Roser, F; Tatagiba, M | 1 |
Apuzzo, ML; Couldwell, WT; Gopalakrishna, R; He, S; Hinton, DR; Law, RE; Weiss, MH | 1 |
Bremen, D; Grimmel, C; Krajewski, S; Reed, JC; Schabet, M; Trepel, M; Weller, M | 1 |
Couldwell, WT; Hinton, DR; Law, RE; Zhang, W | 1 |
Anker, L; Couldwell, WT; Gopalakrishna, R; Gundimeda, U; Hinton, DR; Law, RE; Pu, Q; Weiss, MH; Zhang, W | 1 |
Beurdeley-Thomas, A; De Pinieux, G; Dutrillaux, B; Miccoli, L; Oudard, S; Poupon, MF; Sureau, F | 1 |
Giese, A; Puchner, MJ | 1 |
1 trial(s) available for perylene and Glioma
Article | Year |
---|---|
A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomas.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anthracenes; Antineoplastic Agents; Brain Neoplasms; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Perylene | 2011 |
26 other study(ies) available for perylene and Glioma
Article | Year |
---|---|
Accumulation and penetration behavior of hypericin in glioma tumor spheroids studied by fluorescence microscopy and confocal fluorescence lifetime imaging microscopy.
Topics: Anthracenes; Brain Neoplasms; Cell Line, Tumor; Glioma; Humans; Microscopy, Fluorescence; Perylene; Photosensitizing Agents | 2022 |
Simple and free-labeled voltammetry determination of glioma cell.
Topics: Biosensing Techniques; Carbon; Glioma; Humans; Immunoassay; Peptides; Perylene; Soot | 2022 |
Importance of Hypericin-Bcl2 interactions for biological effects at subcellular levels.
Topics: Aniline Compounds; Anthracenes; Cell Line, Tumor; Cell Survival; Fluorescence; Glioma; Humans; Molecular Docking Simulation; Molecular Structure; Perylene; Photochemotherapy; Photosensitizing Agents; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Tryptophan; Tyrosine | 2019 |
Synergism between PKCδ regulators hypericin and rottlerin enhances apoptosis in U87 MG glioma cells after light stimulation.
Topics: Acetophenones; Angiogenesis Inhibitors; Anthracenes; Antineoplastic Agents; Apoptosis; Benzopyrans; Cell Line, Tumor; Cell Survival; Gene Expression Regulation; Glioma; Humans; Light; Perylene; Photochemotherapy; Protein Kinase C-delta; Radiation-Sensitizing Agents | 2017 |
Bcl-2 proapoptotic proteins distribution in U-87 MG glioma cells before and after hypericin photodynamic action.
Topics: Anthracenes; Apoptosis; Cell Line, Tumor; Glioma; Humans; Light; Perylene; Photochemotherapy; Photosensitizing Agents; Proto-Oncogene Proteins c-bcl-2; Subcellular Fractions; Tissue Distribution; Treatment Outcome | 2013 |
Microendoscopy for hypericin fluorescence tumor diagnosis in a subcutaneous glioma mouse model.
Topics: Animals; Anthracenes; Brain Neoplasms; Cell Line, Tumor; Disease Models, Animal; Endoscopy; Glioma; Metabolic Clearance Rate; Mice; Perylene; Photosensitizing Agents; Reproducibility of Results; Sensitivity and Specificity; Skin Neoplasms; Spectrometry, Fluorescence; Tissue Distribution | 2013 |
The role of anti-apoptotic protein kinase Cα in response to hypericin photodynamic therapy in U-87 MG cells.
Topics: Anthracenes; Apoptosis Regulatory Proteins; Cell Line, Tumor; Glioma; Humans; Perylene; Phosphorylation; Photochemotherapy; Photosensitizing Agents; Protein Kinase C-alpha; Proto-Oncogene Proteins c-bcl-2; Treatment Outcome | 2014 |
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.
Topics: Adaptive Immunity; Animals; Anthracenes; Apoptosis; Brain Neoplasms; Cancer Vaccines; CD8-Positive T-Lymphocytes; Cell Death; Dendritic Cells; Endoplasmic Reticulum Stress; Glioma; Mice; Mice, Inbred C57BL; Neoplasm Grading; Perylene; Photochemotherapy; Reactive Oxygen Species; T-Lymphocytes, Cytotoxic | 2016 |
Deeper insights into the drug defense of glioma cells against hydrophobic molecules.
Topics: Anthracenes; Anthraquinones; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Nucleus; Cholesterol, LDL; DNA; Emodin; Glioma; Humans; Hydrophobic and Hydrophilic Interactions; Light; Molecular Docking Simulation; Perylene; Serum Albumin | 2016 |
Estimation of PKCδ autophosphorylation in U87 MG glioma cells: combination of experimental, conceptual and numerical approaches.
Topics: Anthracenes; Blotting, Western; Cell Line, Tumor; Cell Nucleus; Ceramides; Computer Simulation; Glioma; Humans; Microscopy, Confocal; Microscopy, Fluorescence; Models, Biological; Optical Imaging; Perylene; Phosphorylation; Protein Kinase C-delta; Signal Transduction; Spectrum Analysis; Time Factors | 2017 |
Assessing light-independent effects of hypericin on cell viability, ultrastructure and metabolism in human glioma and endothelial cells.
Topics: Anthracenes; Apoptosis; Cell Line, Tumor; Cell Respiration; Endothelial Cells; Glioma; Glycolysis; Humans; Light; Membrane Potential, Mitochondrial; Oxidative Stress; Perylene; Photosensitizing Agents | 2017 |
The flashlights on a distinct role of protein kinase C δ: Phosphorylation of regulatory and catalytic domain upon oxidative stress in glioma cells.
Topics: Algorithms; Anthracenes; Apoptosis; Brain Neoplasms; Catalytic Domain; Cell Line, Tumor; Glioma; Humans; Light; Microscopy, Electron; Microscopy, Fluorescence; Mitochondria; Oxidative Stress; Perylene; Phosphorylation; Protein Kinase C-delta; Proto-Oncogene Proteins c-bcl-2 | 2017 |
Comment on "Hypericin uptake: a prognostic marker for survival in high-grade glioma".
Topics: Anthracenes; Brain Neoplasms; Glioma; Humans; Perylene | 2009 |
Interaction dynamics of hypericin with low-density lipoproteins and U87-MG cells.
Topics: Anthracenes; Cell Line, Tumor; Cell Membrane; Fluorescence; Glioma; Humans; Hydrophobic and Hydrophilic Interactions; Lipoproteins, LDL; Perylene; Photosensitizing Agents | 2010 |
Selective enrichment of hypericin in malignant glioma: pioneering in vivo results.
Topics: Animals; Anthracenes; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Glioma; Male; Neoplasm Transplantation; Perylene; Rats; Rats, Wistar | 2011 |
Hypericin for visualization of high grade gliomas: first clinical experience.
Topics: Aged; Anthracenes; Brain Neoplasms; Female; Fluorescence; Glioma; Humans; Injections, Intravenous; Male; Middle Aged; Perylene; Photosensitizing Agents; Predictive Value of Tests; Sensitivity and Specificity | 2012 |
Cell death response of U87 glioma cells on hypericin photoactivation is mediated by dynamics of hypericin subcellular distribution and its aggregation in cellular organelles.
Topics: Anthracenes; Apoptosis; Cell Line, Tumor; Endocytosis; Fluorescence Resonance Energy Transfer; Glioma; Humans; Lipoproteins, LDL; Membrane Potential, Mitochondrial; Microscopy, Confocal; Organelles; Perylene; Photosensitizing Agents | 2012 |
Hypericin-an inhibitor of proteasome function.
Topics: Anthracenes; Antidepressive Agents; Electrophoretic Mobility Shift Assay; Glioma; Humans; Mammary Neoplasms, Animal; NF-kappa B; Perylene; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Tumor Cells, Cultured | 2005 |
Photodynamic therapy of malignant glioma with hypericin: comprehensive in vitro study in human glioblastoma cell lines.
Topics: Anthracenes; Brain Neoplasms; Cell Line, Tumor; Cell Membrane; Glioblastoma; Glioma; Humans; Light; Microscopy, Fluorescence; Perylene; Photochemotherapy; Photosensitizing Agents; Time Factors | 2007 |
Hypericin uptake: a prognostic marker for survival in high-grade glioma.
Topics: Adult; Aged; Anthracenes; Astrocytoma; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Disease-Free Survival; Drug Resistance, Neoplasm; Drug Therapy; Female; Fluorescence; Glioblastoma; Glioma; Humans; Light; Lipoproteins, LDL; Male; Microscopy, Fluorescence; Middle Aged; Models, Statistical; Perylene; Photochemotherapy; Predictive Value of Tests; Prognosis; Radiation-Sensitizing Agents; Radiotherapy; Survival Rate | 2008 |
Hypericin: a potential antiglioma therapy.
Topics: Anthracenes; Apoptosis; Brain Neoplasms; Cell Division; Cell Line; Cell Survival; DNA Damage; Dose-Response Relationship, Drug; Glioma; Humans; Perylene; Phototherapy; Protein Kinase C; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1994 |
Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53.
Topics: Anthracenes; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Apoptosis; bcl-2-Associated X Protein; Cell Division; Drug Resistance; fas Receptor; Glioma; Humans; Light; Naphthalenes; Perylene; Protein Kinase C; Protein Synthesis Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; RNA; Tamoxifen; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1997 |
Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor.
Topics: Anthracenes; Antineoplastic Agents; Brain Neoplasms; Cell Movement; Cells, Cultured; Enzyme Inhibitors; Glioma; Humans; Neoplasm Invasiveness; Perylene; Protein Kinase C | 1997 |
Enhancement of radiosensitivity in human malignant glioma cells by hypericin in vitro.
Topics: Anthracenes; Glioma; Humans; Perylene; Protein Kinase C; Radiation-Sensitizing Agents; Tumor Cells, Cultured | 1996 |
Light-induced photoactivation of hypericin affects the energy metabolism of human glioma cells by inhibiting hexokinase bound to mitochondria.
Topics: Anthracenes; Apoptosis; Energy Metabolism; Enzyme Inhibitors; Glioma; Hexokinase; Humans; Hydrogen-Ion Concentration; Light; Mitochondria; Perylene; Radiation-Sensitizing Agents; Thymidine; Tumor Cells, Cultured | 1998 |
Tamoxifen-resistant glioma-cell sub-populations are characterized by increased migration and proliferation.
Topics: Anthracenes; Antineoplastic Agents, Hormonal; Cell Division; Cell Movement; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Glioma; Humans; Perylene; Protein Kinase C; Staurosporine; Tamoxifen; Tumor Cells, Cultured | 2000 |